Research

Whitman and Yang

Drs. Whitman and Yang Will Lead HSDM’s Office of Research

September 25, 2018

Dr. Malcolm Whitman and Dr. Yingzi Yang, both professors of Developmental Biology at Harvard School of Dental Medicine (HSDM), have been tapped to lead HSDM’s Office of Research. Beginning October 1, 2018, Dr. Whitman will become associate dean for basic science, and Dr. Yang will become associate dean for translational research. In these new roles, they will share the responsibility of leading HSDM’s research efforts – promoting, overseeing, and reviewing all research activities at HSDM.  

... Read more about Drs. Whitman and Yang Will Lead HSDM’s Office of Research

Dr. Yang

Research Profile: Gaining Insights from Rare Genetic Diseases

July 11, 2018

Dr. Yingzi Yang, professor of developmental biology at HSDM, leads a laboratory of seven postdoctoral researchers and three visiting scholars researching skeletal development—particularly how the skeletal system forms and how skeletal diseases arise.

“We have a long-standing interest in skeletal development, although most of the time we are investigating how the skeletal system forms, our ultimate goal is to understand the cellular and molecular mechanisms underpinning skeletal diseases,” Yang said...

Read more about Research Profile: Gaining Insights from Rare Genetic Diseases
3DOrthoImage

New Research Led by HSDM Suggests 3D Photography Could Offer Better Orthodontic Diagnosis Using Less Radiation

June 27, 2017

Common orthodontic problems such as crossbite, overbite, underbite, and crowding of the teeth can have a negative impact on a person’s physical appearance, dental function, and overall self esteem. To make a diagnosis and plan treatment, orthodontists currently take multiple x-ray images of the entire skull before, during and after orthodontic treatment. ... Read more about New Research Led by HSDM Suggests 3D Photography Could Offer Better Orthodontic Diagnosis Using Less Radiation

PTH hormone

Lanske Lab Research Finding Could Influence Treatment of Osteoporosis and Other Diseases

April 17, 2017

Researchers in the Lanske Laboratory at Harvard School of Dental Medicine (HSDM) in collaboration with the Rosen Laboratory at Maine Medical Center have been studying the function of Parathyroid hormone (PTH) beyond its well-known role in maintaining calcium homeostasis in the body. PTH has been approved for treatment of osteoporosis in humans to induce bone formation. Their recent finding published in...

Read more about Lanske Lab Research Finding Could Influence Treatment of Osteoporosis and Other Diseases
Cells

Intini Lab Research Leads to Collaboration with Boston Children's Hospital Surgeons on Potential Treatments for Craniofacial Malformations

April 5, 2017

A recent research finding published in Stem Cell Reports could potentially lead to therapies that address craniofacial malformations in children. Craniofacial malformations are deformities that affect a child’s head and facial bones—disorders such as cleft palate, or craniosynostosis that are present at birth.

...

Read more about Intini Lab Research Leads to Collaboration with Boston Children's Hospital Surgeons on Potential Treatments for Craniofacial Malformations
2016-2017 Dean’s Scholars Announced

2016-2017 Dean’s Scholars Announced

September 13, 2016

Today, the HSDM community gathered to celebrate the newest Dean's Scholars. Dean Bruce Donoff presented the awards at a special tea held in the Research and Education Building. The Dean’s Scholars program provides dedicated time and funding for outstanding individuals to develop and refine the skills necessary for future success in academics and research. This years’ award recipients are:

Shek Man (Jacky) Chim research fellow in Developmental Biology and member of the Rosen Lab. Chim received an award for his project on the interplay of BMP and activin...

Read more about 2016-2017 Dean’s Scholars Announced
New Study by HSDM Researchers May Have Implications for Treating Osteoporosis

New Study by HSDM Researchers May Have Implications for Treating Osteoporosis

June 30, 2016

As we age, every stumble or fall comes with a risk—a risk that is even greater for those ten million people in the U.S. who have osteoporosis, a skeletal disease characterized by low bone mass, poor bone quality and fractures. Each year, 1.5 million bone fractures are attributed to osteoporosis, including 350,000 hip fractures. But hip or other fractures in older and osteoporotic patients do not heal easily and this often leads to significant impairments in daily life, and even death.

Dr. Roland Baron, professor and chair of...

Read more about New Study by HSDM Researchers May Have Implications for Treating Osteoporosis
Professor Malcolm Whitman Gets Backing of Allied-Bristol Life Sciences (ABLS)

Professor Malcolm Whitman Gets Backing of Allied-Bristol Life Sciences (ABLS)

July 6, 2015

Dr. Malcolm Whitman, PHD87, HSDM professor of developmental biology, and Tracy Keller, SM87, PHD96, an instructor in the Department of Developmental Biology, have identified a chemical compound based on an active ingredient in the root of the blue evergreen hydrangea (Dichroa febrifuga), that could lead to treatment of chronic fibrotic and autoimmune diseases. The root has been used in traditional Chinese medicine for centuries. Whitman and Keller identified the mechanism of action, halofuginone (HF), found within the root.

Now, Allied-Bristol Life Sciences (ABLS) a...

Read more about Professor Malcolm Whitman Gets Backing of Allied-Bristol Life Sciences (ABLS)

Pages